Cardiovascular 15-64 years: No 0.8 per 10 µg/m3 0.6% (0.3-0.9%) per n/a n/a No CRF effect (no 95%CI 10 µg/m3 recommended. 65+ years: No effect provided) () () () ICD9: 390-429 No effect in 24-hour average (based on COMEAP Age: All ages. Australian 4-cities Lag 01 1998) meta-analysis (). Low heterogeneity Meta-analysis of 4 No effect CRF from the study cities - Brisbane, () by Morgan et al () Melbourne, Perth CRF not intended may be used in a Sydney. for health risk sensitivity analysis. ICD9: 390-459; assessment ICD10: I00–I99 purposes. (excluding I67.3, 6 studies I68.0, I88, I97.8, ICD9: 390-459 I97.9, I98.0), Age: All ages. G45 (excluding G45.3), G46, M30, M31, R58 1.22% (0.41 to 2.03%) per 10 µg/m3 () Sydney Age: All ages. 24-hour average ICD9: 390-459; ICD10: I00-I99 (excluding I67.3, I68.0, I88, I97.8, I97.9, I98.0), G45 (excluding G45.3), G46, M30,
Cardiovascular 15-64 years: No effect 65+ years: No effect () 24-hour average Lag 01 Low heterogeneity Meta-analysis of 4 cities - Brisbane, Melbourne, Perth Sydney. ICD9: 390-459; ICD10: I00–I99 (excluding I67.3, I68.0, I88, I97.8, I97.9, I98.0), G45 (excluding G45.3), G46, M30, M31, R58 1.22% (0.41 to 2.03%) per 10 µg/m3 () Sydney Age: All ages. 24-hour average ICD9: 390-459; ICD10: I00-I99 (excluding I67.3, I68.0, I88, I97.8, I97.9, I98.0), G45 (excluding G45.3), G46, M30, 0.8 per 10 µg/m3 (no 95%CI provided) () (based on COMEAP 1998) No effect () CRF not intended for health risk assessment purposes. 6 studies ICD9: 390-459 Age: All ages. 0.6% (0.3-0.9%) per 10 µg/m3 () ICD9: 390-429 Age: All ages. n/a n/a No CRF recommended. No effect in Australian 4-cities meta-analysis (). CRF from the study by Morgan et al () may be used in a sensitivity analysis.
health-report.docx